Removal of inflammatory cytokines and endotoxin by veno-venous continuous renal replacement therapy for burned patients with sepsis

被引:115
作者
Peng, YZ [1 ]
Yuan, ZQ [1 ]
Li, HB [1 ]
机构
[1] Third Mil Med Univ, Inst Burn Res, SW Hosp, Chongqing 400038, Peoples R China
关键词
continuous renal replacement therapy; burn; sepsis; endotoxin; cytokine; inflammatory;
D O I
10.1016/j.burns.2005.02.004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: To evaluate the effect of veno-venous continuous renal replacement therapy (CRRT) on the plasma levels of endotoxin and cytokines in severely burned patients with sepsis. Methods: Twenty adult severely burned patients with sepsis were studied. For the diagnosis of sepsis, patients were randomly divided into CRRT (n = 10) and Control (it = 10). Both groups received conventional therapy after admission. Veno-venous CRRT was administered to 10 patients in the CRRT group whenever patients were determined to be septic. The plasma level of endotoxin, TNF-alpha, IL-1 beta, IL-6 and IL-8 were measured at 0, 1, 2, 6, t2, 36 and 60 h after CRRT initiation, and at 0, 12, 36 and 60 h after the patients were diagnosed as having sepsis in the Control group. Main Results: Plasma level of endotoxin and all the cytokines after CRRT initiation were significantly lower than those before the treatment (P < 0.01). The serial change of endotoxin, IL-1 beta, IL-6 and IL-8 was significantly lower at 12, 36 and 60 h after treatment compared with Control groups (P < 0.01). A significant decrease in plasma TNF-alpha levels was seen at 36 and 60 h after treatment compared with Control groups (P < 0.01). Conclusion: Plasma endotoxin and cytokines (TNF-alpha, IL-1 beta, IL-6 and IL-8) can be removed effectively with CRRT in severely burned patients with sepsis. (C) 2005 Elsevier Ltd and ISBI. All rights reserved.
引用
收藏
页码:623 / 628
页数:6
相关论文
共 21 条
[11]   Renal failure and renal replacement therapy [J].
Maxvold, NJ ;
Bunchman, TE .
CRITICAL CARE CLINICS, 2003, 19 (03) :563-+
[12]  
Mehta R L, 1997, Adv Ren Replace Ther, V4, P81
[13]   Continuous renal replacement therapy: Opinions and evidence [J].
Ronco, C ;
Bellomo, R ;
Kellum, JA .
ADVANCES IN RENAL REPLACEMENT THERAPY, 2002, 9 (04) :229-244
[14]   Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: The Japanese experience [J].
Sato, T ;
Shoji, T ;
Koga, N .
THERAPEUTIC APHERESIS AND DIALYSIS, 2003, 7 (02) :252-258
[15]   REMOVAL OF PRO-INFLAMMATORY CYTOKINES WITH RENAL REPLACEMENT THERAPY - SENSE OR NONSENSE [J].
SCHETZ, M ;
FERDINANDE, P ;
VANDENBERGHE, G ;
VERWAEST, C ;
LAUWERS, P .
INTENSIVE CARE MEDICINE, 1995, 21 (02) :169-176
[16]   Endotoxin and cytokine removal in sepsis [J].
Tetta, C ;
Bellomo, T ;
Inguaggiato, P ;
Wratten, ML ;
Ronco, C .
THERAPEUTIC APHERESIS, 2002, 6 (02) :109-115
[17]   Problems and advantages of continuous renal replacement therapy [J].
Thomas, MC ;
Harris, DC .
NEPHROLOGY, 2002, 7 (03) :110-114
[18]   Venovenous continuous renal replacement therapy for burned patients with acute renal failure [J].
Tremblay, R ;
Ethier, J ;
Quérin, S ;
Béroniade, V ;
Falardeau, P ;
Leblanc, M .
BURNS, 2000, 26 (07) :638-643
[19]  
Ulrich D, 2001, Handchir Mikrochir Plast Chir, V33, P262, DOI 10.1055/s-2001-16595
[20]   Endotoxin removal by direct hemoperfusion with an adsorbent column using polymyxin B-immobilized fiber ameliorates systemic circulatory disturbance in patients with septic shock [J].
Uriu, K ;
Osajima, A ;
Hiroshige, K ;
Watanabe, H ;
Aibara, K ;
Inada, Y ;
Segawa, K ;
Anai, H ;
Takagi, L ;
Ito, A ;
Kamochi, M ;
Kaizu, K .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (05) :937-947